Fire Earth

Earth is fighting to stay alive. Mass dieoffs, triggered by anthropogenic assault and fallout of planetary defense systems offsetting the impact, could begin anytime!

Archive for the ‘A (H1N1) virus’ Category

Up to 40 Japanese Schoolgirls Hit by NZ Swine flu

Posted by feww on October 17, 2009

As up to 40 more than 50 Japanese Schoolgirls Quarantined for Suspected Swine Flu in New Zealand …

Blogger TEAA asks:

Why Are Japanese Schools Allowed to Endanger the Health  of Their Pupils, Nation

Earlier today, NZ media reported that more than 40 visiting Japanese schoolgirls from a party of 200 had shown symptoms of swine flu, with five of them diagnosed with the disease.

Previously the Moderators asserted that:

  • The A (H1N1) virus [commonly known as ‘swine flu’] originated in New Zealand.
  • They also postulated that the ESR labs in New Zealand had produced the virus, and possibly a number of its stronger mutations, on behalf of a client, namely the international pharmaceutical cartel.

In June 2009, it was revealed that a US scientist had been forced to say that he had been “misquoted”  saying the swine flu virus originated in “either New Zealand or China.”

Professor Gus Kousoulas, the director of Louisiana State University’s division of biotechnology and molecular medicine, had been quoted as saying: “We think it [swine flu] began in New Zealand or China,” adding that his conclusion “was based on early phylogenetic analysis of available sequences.”

In April 2009, MSRB Moderators posited that Swine Flu was A Deadly $100 billion Scam. They wrote: “Is this the “perfect” viral mutation engineered to kill only a small number of  ‘brown’ people? [So as to warrant WHO raising its alert level to phase 5, possibly beyond, justifying governments to spend billions of dollars on flu drugs!]

For the rest of Swine Flu “Mystery” see links below:

Swine Flu: A Deadly $100 $600 billion Scam

Updates, additional news and background reading are posted in the comment section at the bottom of each page.

Posted in A (H1N1) virus, ESR lab, health news, new zealand, public health, Swine flu, viral outbreak | Tagged: , , , , , , , , , , , , , , | Leave a Comment »

Swine Flu Pandemic: Pharmaceuticals Payday

Posted by feww on June 11, 2009

WHO’s done it: Swine flu scam enters $600 billion phase!

Responding to pharmaceuticals business emergency, WHO ‘phinally’ declares swine flu ‘phandemic’

Here are some of the issues to consider:

1. Swine flu is a ‘phandemic’; it’s a ‘pandemic’  created by the World Health Organization (WHO), for pharmaceuticals. [See background, and scam  details.]

2. The recent influenza A(H1N1) viral mutation was most likely laboratory-engineered by/ for the multinational pharmaceuticals.

3. Flu viruses, laboratory-engineered or not, are pharmaceuticals’ ‘backbone’ business, especially when they’re elevated into a “pandemic.” They’re exploited as global, wholesale, long-term lucrative trade prospects. As WHO’s top flu expert Keiji Fukuda said: “When you’re talking about pandemic influenza, you are talking about a marathon, you are not talking about a sprint.”

4. The “flu experts” on whose advice the WHO supposedly acts, are pals of the same order eating from the same trough. If there are any ‘independent’ experts anywhere in the world, and don’t bet your life on finding one, they could only arrive at the same [desired] conclusion concerning a ‘pandemic’ because they’d be looking at the same set of flu data provided by the WHO.

5. To keep all other conditions normal, preventing  any  animosity/ rivalry between the pharmaceuticals and the other industries over potential loss of trade opportunities, and no doubt “acting on the recommendation of flu experts,”  the WHO has again advised its 193 member countries “not to close borders or impose travel restrictions to halt the movement of people, goods and services,” a call which has been approved and “echoed by U.N. Secretary-General Ban Ki-moon.

6. The languishing pharmaceuticals are not immune to the impacts of global economic slowdown. [Though they are clearly more enterprising than other industries, and can bank on the WHO to bail them out every time!]

7. When asked, Dr Thomas Frieden, new director of the U.S. Centers for Disease Control and Prevention, told a news conference: “This is not a surprise… It is expected based on the data.”

World now at the start of 2009 influenza pandemic – WHO Director-General Dr Margaret Chan

Her full statement to the press:

Dr Margaret Chan – Director-General of the World Health Organization

Ladies and gentlemen,

In late April, WHO announced the emergence of a novel influenza A virus.

This particular H1N1 strain has not circulated previously in humans. The virus is entirely new.

The virus is contagious, spreading easily from one person to another, and from one country to another. As of today, nearly 30,000 confirmed cases have been reported in 74 countries.

This is only part of the picture. With few exceptions, countries with large numbers of cases are those with good surveillance and testing procedures in place.

Spread in several countries can no longer be traced to clearly-defined chains of human-to-human transmission. Further spread is considered inevitable.

I have conferred with leading influenza experts, virologists, and public health officials. In line with procedures set out in the International Health Regulations, I have sought guidance and advice from an Emergency Committee established for this purpose.

On the basis of available evidence, and these expert assessments of the evidence, the scientific criteria for an influenza pandemic have been met.

I have therefore decided to raise the level of influenza pandemic alert from phase 5 to phase 6.

The world is now at the start of the 2009 influenza pandemic.

We are in the earliest days of the pandemic. The virus is spreading under a close and careful watch.

No previous pandemic has been detected so early or watched so closely, in real-time, right at the very beginning. The world can now reap the benefits of investments, over the last five years, in pandemic preparedness.

We have a head start. This places us in a strong position. But it also creates a demand for advice and reassurance in the midst of limited data and considerable scientific uncertainty.

Thanks to close monitoring, thorough investigations, and frank reporting from countries, we have some early snapshots depicting spread of the virus and the range of illness it can cause.

We know, too, that this early, patchy picture can change very quickly. The virus writes the rules and this one, like all influenza viruses, can change the rules, without rhyme or reason, at any time.

Globally, we have good reason to believe that this pandemic, at least in its early days, will be of moderate severity. As we know from experience, severity can vary, depending on many factors, from one country to another.

On present evidence, the overwhelming majority of patients experience mild symptoms and make a rapid and full recovery, often in the absence of any form of medical treatment.

Worldwide, the number of deaths is small. Each and every one of these deaths is tragic, and we have to brace ourselves to see more. However, we do not expect to see a sudden and dramatic jump in the number of severe or fatal infections.

We know that the novel H1N1 virus preferentially infects younger people. In nearly all areas with large and sustained outbreaks, the majority of cases have occurred in people under the age of 25 years.

In some of these countries, around 2% of cases have developed severe illness, often with very rapid progression to life-threatening pneumonia.

Most cases of severe and fatal infections have been in adults between the ages of 30 and 50 years.

This pattern is significantly different from that seen during epidemics of seasonal influenza, when most deaths occur in frail elderly people.

Many, though not all, severe cases have occurred in people with underlying chronic conditions. Based on limited, preliminary data, conditions most frequently seen include respiratory diseases, notably asthma, cardiovascular disease, diabetes, autoimmune disorders, and obesity.

At the same time, it is important to note that around one third to half of the severe and fatal infections are occurring in previously healthy young and middle-aged people.

Without question, pregnant women are at increased risk of complications. This heightened risk takes on added importance for a virus, like this one, that preferentially infects younger age groups.

Finally, and perhaps of greatest concern, we do not know how this virus will behave under conditions typically found in the developing world. To date, the vast majority of cases have been detected and investigated in comparatively well-off countries.

Let me underscore two of many reasons for this concern. First, more than 99% of maternal deaths, which are a marker of poor quality care during pregnancy and childbirth, occurs in the developing world.

Second, around 85% of the burden of chronic diseases is concentrated in low- and middle-income countries.

Although the pandemic appears to have moderate severity in comparatively well-off countries, it is prudent to anticipate a bleaker picture as the virus spreads to areas with limited resources, poor health care, and a high prevalence of underlying medical problems.

Ladies and gentlemen,

A characteristic feature of pandemics is their rapid spread to all parts of the world. In the previous century, this spread has typically taken around 6 to 9 months, even during times when most international travel was by ship or rail.

Countries should prepare to see cases, or the further spread of cases, in the near future. Countries where outbreaks appear to have peaked should prepare for a second wave of infection.

Guidance on specific protective and precautionary measures has been sent to ministries of health in all countries. Countries with no or only a few cases should remain vigilant.

Countries with widespread transmission should focus on the appropriate management of patients. The testing and investigation of patients should be limited, as such measures are resource intensive and can very quickly strain capacities.

WHO has been in close dialogue with influenza vaccine manufacturers. I understand that production of vaccines for seasonal influenza will be completed soon, and that full capacity will be available to ensure the largest possible supply of pandemic vaccine in the months to come.

Pending the availability of vaccines, several non-pharmaceutical interventions can confer some protection.

WHO continues to recommend no restrictions on travel and no border closures.

Influenza pandemics, whether moderate or severe, are remarkable events because of the almost universal susceptibility of the world’s population to infection.

We are all in this together, and we will all get through this, together.

Thank you. [NO, thank you! Really!]

Related Links:

[NOTE: IF you use the term ‘phandemic’ in the above context, quote this source!]

Posted in $600 billion scam, A (H1N1) virus, Double Psychology, flu vaccines, Swine Flu Mystery | Tagged: , , , , | 3 Comments »

More on Swine Flu

Posted by feww on April 25, 2009

UPDATE: Mexican govt says new flu virus probably killed 81

Flu virus particles, or “virions”

This colorized negative-stained transmission electron micrograph (TEM) depicts the ultrastructural details of a number of influenza virus particles, or “virions”. A member of the taxonomic family Orthomyxoviridae, the influenza virus is a single-stranded RNA organism. CDC/ Courtesy of Dr. F. A. Murphy (1973).

The flu is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness, and at times can lead to death. The best way to prevent this illness is by getting a flu vaccination each fall.

Every year in the United States, on average:

  • 5% to 20% of the population gets the flu
  • more than 200,000 people are hospitalized from flu complications, and
  • about 36,000 people die from flu. Some people, such as older people, young children, and people with certain health conditions, are at high risk for serious flu complications.

What you should know:

Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin and neuraminidase. Influenza B viruses are not categorized into subtypes. Since 1977, influenza A (H1N1) viruses, influenza A (H3N2) viruses, and influenza B viruses have been in global circulation. In 2001, influenza A (H1N2) viruses that probably emerged after genetic reassortment between human A (H3N2) and A (H1N1) viruses began circulating widely. Both influenza A and B viruses are further separated into groups on the basis of antigenic characteristics. New influenza virus variants result from frequent antigenic change (i.e., antigenic drift) resulting from point mutations that occur during viral replication. Influenza B viruses undergo antigenic drift less rapidly than influenza A viruses.

CDC – Key Facts about Swine Influenza (Swine Flu)

Under a plate magnification of 37,800X, this colorized transmission electron micrograph (TEM) depicted the A/New Jersey/76 (Hsw1N1) virus, while in the virus’ first developmental passage through a chicken egg. CDC/ Dr. E. Palmer; R.E. Bates (1976).

What is Swine Influenza?

Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza that regularly cause outbreaks of influenza among pigs. Swine flu viruses cause high levels of illness and low death rates among pigs. Swine influenza viruses may circulate in swine throughout the year, but most outbreaks among swine herds occur during the late fall and winter months similar to humans. The classical swine flu virus (an influenza type A H1N1 virus) was first isolated from a pig in 1930.

Can humans catch swine flu? [YES THEY CAN! They already have! Moderator.]

Swine flu viruses do not normally infect humans. However, sporadic human infections with swine flu have occurred. In the past several years, on average CDC has received about one influenza virus isolate from a human that tests positive for swine flu each year. Most commonly, these cases occur in persons with direct exposure to pigs (workers in the swine industry, for example). In addition, there have been rare documented cases of one person spreading swine flu to others. For example, an outbreak of apparent swine flu infection in pigs in Wisconsin in 1988 resulted in multiple human infections, and, although no community outbreak resulted, there was antibody evidence of virus transmission from the patient to health care workers who had close contact with the patient.

This negative-stained transmission electron micrograph (TEM) depicts the ultrastructural details of an influenza virus particle, or “virion”. A member of the taxonomic family Orthomyxoviridae, the influenza virus is a single-stranded RNA organism.  Dated: 1981.  CDC/ Dr. Erskine. L. Palmer; Dr. M. L. Martin

This negative stained transmission electron micrograph (TEM) shows recreated 1918 influenza virions that were collected from supernatants of 1918-infected Madin-Darby Canine Kidney (MDCK) cells cultures 18 hours after infection. CDC/ Dr. Terrence Tumpey (2005)

To separate these virions, the MDCK cells are spun down (centrifugation), and the 1918 virus in the fluid is immediately fixed for negative staining. The solid mass in lower center contains MDCK cell debris that did not spin down during the procedure. See PHIL 8160 for a black and white version of this micrograph.

Dr. Terrence Tumpey, one of the organization’s staff microbiologists and a member of the National Center for Infectious Diseases (NCID), recreated the 1918 influenza virus in order to identify the characteristics that made this organism such a deadly pathogen. Research efforts such as this, enables researchers to develop new vaccines and treatments for future pandemic influenza viruses.

The 1918 Spanish flu epidemic was caused by an influenza A (H1N1) virus, killing more than 500,000 people in the United States, and up to 50 million worldwide. The possible source was a newly emerged virus from a swine or an avian host of a mutated H1N1 virus. Many people died within the first few days after infection, and others died of complications later. Nearly half of those who died were young, healthy adults. Influenza A (H1N1) viruses still circulate today after being introduced again into the human population in the 1970s.

The information on his page was provided by CDC.

Related Links:

  • http:/www.pandemicflu.gov/
  • http:/www.who.int/en/

Posted in A (H1N1) virus, A (H3N2), antigenic drift, genetic reassortment, Influenza B | Tagged: , , , | 3 Comments »

Swine flu kills dozens in Mexico

Posted by feww on April 24, 2009

Swine flu kills 60 people and sickens 1,000  others in Mexico

60 people have died and hundreds more have been infected by a viral outbreak in Mexico believed to be a new strain of swine flu.

The cases are centered around Mexico City since mid-March, World Health Organization (WHO) said, prompting the authorities to close schools and launching a vaccination campaign in affected areas.

57  people died in Mexico City and another three in San Luis Potosi in central Mexico, with nearly a 1,000 suspected cases reported.

The infections follow seven non-fatal cases of a new form of swine flu confirmed in California and Texas, where tests are being carried out to establish if the two strains are linked.

Mexico’s Health Minister said the virus seems to have  “mutated from pigs and then at some point was transmitted to humans.”

“This is the first time that we’ve seen an avian strain, two swine strains and a human strain,” a spokesperson for the US Center for Disease Control and Prevention (CDC) told the media.

The seven victims in the United States had NOT been in contact with pigs, which is how the swine flu virus would normally have been transmitted.

Related Links:

Posted in A (H1N1) virus, health news, Human Swine flue, public health, San Luis Potosi | Tagged: , , , , | 5 Comments »